By Judith Wenshuk, peptide research writer
Quick Answer: 5-Amino-1MQ is a small-molecule NNMT inhibitor, studied for its potential role in cellular metabolism and fat storage regulation. Inhibiting the NNMT enzyme is believed to affect how cells manage energy metabolism, which is the basis for its research interest in metabolic and fat-loss contexts.
5-Amino-1MQ isn’t a peptide — it’s a small-molecule compound — but it’s grouped with research peptides due to overlapping interest in metabolic research. It’s available in Canada through research peptide suppliers.
What Is NNMT, and Why Inhibit It?
NNMT (nicotinamide N-methyltransferase) is an enzyme involved in cellular energy metabolism. Research suggests NNMT activity increases in fat tissue as metabolic function declines, which has driven interest in whether inhibiting it — the mechanism 5-Amino-1MQ is studied for — could influence metabolic regulation and fat storage.
What It’s Studied For
- Metabolic regulation research — its core mechanism of interest
- Fat storage and fat-loss-adjacent research — tied to NNMT’s role in fat tissue metabolism
How Established Is the Research?
Similar to SLU-PP-332, 5-Amino-1MQ’s research base is still developing — the NNMT-inhibition mechanism is a genuinely active area of metabolic research, but it doesn’t yet have the large-scale trial history of compounds like the GLP-1 family.
Frequently Asked Questions
Is 5-Amino-1MQ a peptide? No — it’s a small-molecule compound, grouped with research peptides due to shared research interest in metabolism.
Is 5-Amino-1MQ available as a research compound in Canada? Yes — 5-Amino-1MQ is available through research peptide suppliers in Canada.
Leave a Reply